Cargando…

Biologics and Biosimilars in Psoriasis

Psoriasis is a chronic, debilitating, relapsing, inflammatory dermatosis, which affects approximately 2-3% of the population. The burgeoning research on pathogenesis of psoriasis has opened up new directions in management of this common condition. The introduction of biologics has given additional e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Sk Shahriar, De, Abhishek, Das, Sudip, Manchanda, Yashpal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389141/
https://www.ncbi.nlm.nih.gov/pubmed/37529455
http://dx.doi.org/10.4103/ijd.ijd_421_23